ATHN Insider Trading Activity and SEC Form 4 Filings
ATHN insider trading summary
No open-market insider purchases or sales of Athenahealth Inc (ATHN) have been reported on SEC Form 4 in the past 12 months.
Latest ATHN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 26, 2018 | Jonathan D. Porter | SVP, Chief Product Officer | Sell | $18K (150 @ $118.33) |
| Oct 1, 2018 | Daniel P Haley | Chief Legal & Admin Officer | Sell | $245K (1,931 @ $127.13) |
| Oct 1, 2018 | Daniel P Haley | Chief Legal & Admin Officer | Sell | $35K (273 @ $127.93) |
| Sep 26, 2018 | Jonathan D. Porter | SVP, Chief Product Officer | Sell | $20K (150 @ $131.51) |
| Aug 27, 2018 | Jonathan D. Porter | SVP, Chief Product Officer | Sell | $23K (150 @ $152.53) |
| Jul 26, 2018 | Jonathan D. Porter | SVP, Chief Product Officer | Sell | $22K (150 @ $146.79) |
| Jun 26, 2018 | Jonathan D. Porter | SVP, Chief Product Officer | Sell | $24K (150 @ $158.15) |
| Jun 1, 2018 | Jonathan Bush | CEO and President | Sell | $389K (2,600 @ $149.74) |
| Jun 1, 2018 | Jonathan Bush | CEO and President | Sell | $332K (2,200 @ $150.85) |
| Jun 1, 2018 | Jonathan Bush | CEO and President | Sell | $30K (200 @ $152.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.